Who Should Not Get Microneedling: A Complete Contraindications Guide for Estheticians

Microneedling is among the most powerful treatments an esthetician can offer. It stimulates collagen induction, supports skin remodeling, enhances product absorption, and delivers visible improvements across a broad range of skin concerns. It is also, when performed on the wrong client, one of the treatments most likely to cause serious harm. That is not a reason to avoid learning the treatment — it is a reason to take contraindication screening seriously as a foundational professional skill, not a formality.

The controlled injury mechanism that makes microneedling effective is the same mechanism that makes it dangerous in the presence of certain skin conditions, medications, systemic health factors, and skin type variables. A treatment that triggers productive wound healing in a well-screened client triggers infection, prolonged inflammation, hyperpigmentation, or hypertrophic scarring in a client who should not have been on the table in the first place.

This guide gives estheticians a complete, systematically organized understanding of who should not receive microneedling. It covers absolute contraindications that are non-negotiable disqualifiers, relative contraindications that require professional judgment and sometimes physician clearance, medication categories that affect safe treatment delivery, skin type variables that demand modified protocols, and the screening process that should be embedded in every intake workflow. Mastering this material is not just about protecting clients — it is how estheticians protect their license, their practice, and their professional reputation.

Understanding Absolute vs. Relative Contraindications in Microneedling

Before reviewing individual contraindications, it is important to distinguish between two categories that carry fundamentally different clinical implications. Conflating them is one of the most common errors in professional microneedling education, and the consequences of misclassification can be serious.

Absolute Contraindications: Non-Negotiable Disqualifiers

An absolute contraindication means the treatment cannot be safely performed under any circumstances while that condition is present or active. There is no modified protocol, reduced needle depth, shorter session time, or additional consent language that makes microneedling appropriate for a client with an active absolute contraindication. The answer is always to decline or defer the treatment, explain the reason professionally, and in some cases refer the client to an appropriate medical provider.

Attempting to perform microneedling on a client with an active absolute contraindication is not a calculated clinical risk — it is an error in professional judgment that exposes the client to serious potential harm and the esthetician to significant liability.

Relative Contraindications: Judgment-Required Situations

A relative contraindication means the treatment may be possible under specific conditions, with physician clearance, with protocol modification, or after the underlying condition has been addressed or has resolved. These situations require estheticians to think carefully, ask more detailed questions, potentially consult with or refer to a physician, and document their decision-making process thoroughly. In some cases, the appropriate answer is still to decline treatment — but the decision requires clinical reasoning rather than a blanket rule.

Understanding which category each condition falls into — and why — is the mark of a professionally educated esthetician who can explain their screening decisions to clients and, if necessary, to licensing boards or insurance providers.

Absolute Contraindications: Conditions That Always Disqualify a Client

The following conditions represent non-negotiable disqualifiers for microneedling in the affected area. When any of these are present at the time of the scheduled appointment, the appropriate professional response is to decline the treatment, document the reason, and rebook when the condition has fully resolved.

Active Acne: Why This Is a Hard Stop

Active acne with open or inflamed lesions is among the most commonly encountered absolute contraindications in treatment room practice. When microneedling is performed over active acne lesions, the needle channels can spread bacteria from the lesion to surrounding skin — dramatically expanding the infection and triggering widespread breakouts in areas that were previously clear. This is not a theoretical risk. Estheticians who have made this error in clinical settings consistently describe the post-treatment outcome as among the most severe client reactions they have witnessed.

Mild, non-inflammatory comedones without open lesions occupy a grayer area — but the default conservative position for any esthetician without advanced clinical training is to treat active acne as an absolute contraindication until the active phase has fully resolved.

Active Herpes Simplex: The Reactivation Risk

Active cold sores are an absolute contraindication. However, the herpes simplex consideration extends beyond active outbreaks. The mechanical trauma of microneedling is a well-documented trigger for herpes simplex reactivation in clients who carry the virus asymptomatically. A client who reports no current cold sore but mentions a history of periodic cold sores is not automatically cleared for treatment. The professional protocol is to include herpes history in the intake form, flag any positive history, and refer that client to their physician for guidance on antiviral prophylaxis before scheduling any microneedling treatment.

Keloid and Hypertrophic Scarring History

Clients with a documented history of keloid or hypertrophic scar formation represent a significant absolute contraindication category. These clients have demonstrated an abnormal wound-healing response — one in which the skin produces excessive fibrous tissue in response to injury. Since microneedling works by creating controlled micro-injuries that trigger a healing response, performing the treatment on a client with keloid tendency risks producing abnormal scar tissue in the treatment area, potentially creating precisely the outcome the client was hoping to improve. This history should be screened for explicitly in every intake form.

Isotretinoin: The Medication Contraindication Most Commonly Missed

Isotretinoin — sold under brand names including Accutane, Claravis, and others — is prescribed for severe or treatment-resistant acne and represents the most frequently underestimated medication contraindication in professional microneedling practice. Many clients who have taken isotretinoin do not spontaneously disclose it during consultations, either because they completed their course months or years ago and do not consider it currently relevant, or because they do not understand its implications for skincare treatments.

Why Isotretinoin Changes Wound Healing

Isotretinoin profoundly alters the skin’s wound-healing capacity for a period that extends significantly beyond the course of treatment itself. The drug reduces sebaceous gland activity, thins the stratum corneum, impairs fibroblast function, and disrupts the normal inflammatory cascade that governs wound repair. In a client on isotretinoin or recently post-course, the microneedling injury does not heal in a normal, controlled, remodeling pattern. Instead, healing is slow, unpredictable, and carries substantially elevated risk of scarring, prolonged barrier disruption, and post-inflammatory hyperpigmentation.

Other Medications That Require Evaluation Before Microneedling

Isotretinoin is the clearest absolute medication contraindication, but several other medication categories require careful evaluation during intake screening. Estheticians should not attempt to make independent clinical judgments about all medication interactions — when uncertainty exists, the appropriate course is to request physician clearance before proceeding.

Fitzpatrick Skin Type Considerations: Who Needs a Modified Protocol

Microneedling is not inherently contraindicated for any Fitzpatrick skin type. However, the risk profile of microneedling changes significantly across the Fitzpatrick scale, and the professional standard of care requires estheticians to adapt their protocols, risk communication, and healing interval planning accordingly.

Why Fitzpatrick IV Through VI Requires a Different Approach

The primary risk that escalates with darker skin tones is post-inflammatory hyperpigmentation (PIH) — the development of darker pigmented patches in areas where controlled skin injury triggered an exaggerated melanocyte response during healing. PIH can be a temporary outcome that resolves over months or a longer-lasting discoloration that profoundly affects client satisfaction and trust.

The physiological mechanism is well understood: melanocytes in deeper Fitzpatrick skin types are more reactive to inflammation signals and more readily produce excess melanin in response to the wound-healing cascade that microneedling triggers. The deeper the needle penetration, the more aggressive the technique, and the more sessions performed in close succession — the higher the PIH risk in susceptible skin types.

Pre-Treatment Protocols for Higher Fitzpatrick Skin Types

Estheticians working with Fitzpatrick IV through VI clients should consider recommending a tyrosinase inhibitor pre-conditioning protocol in the weeks leading up to microneedling. This approach, which typically involves a niacinamide, kojic acid, alpha-arbutin, or similar tyrosinase-inhibiting topical regimen applied for four to six weeks pre-treatment, is designed to reduce melanocyte reactivity before the treatment-induced inflammation begins. However, recommending a pre-conditioning protocol that involves prescription-strength agents requires physician involvement. Estheticians should discuss this pathway with clients and facilitate appropriate medical referrals rather than attempting to design the protocol independently.

Relative Contraindications: When Physician Clearance Changes the Answer

Several client situations represent relative contraindications where the appropriate response is not an automatic refusal, but a more thorough evaluation process that may involve deferring treatment pending physician input.

Diabetes and Wound Healing

Poorly controlled diabetes fundamentally impairs the wound-healing cascade that microneedling depends on for its mechanism of action. Elevated blood glucose levels disrupt collagen synthesis, impair fibroblast function, reduce microvascular blood flow, and compromise immune function — all of which are directly relevant to the healing response that follows controlled skin injury. Clients with a diabetes diagnosis should provide physician clearance confirming stable glycemic control before microneedling is performed. Well-controlled diabetes with documented physician oversight represents a lower risk profile than uncontrolled or poorly managed blood glucose levels.

Recent Injectables: The Timing Window

Clients who have recently received Botox, neurotoxin, or dermal filler injections require a waiting period before microneedling can be safely performed in adjacent areas. The general professional guideline is a minimum of two weeks post-neurotoxin and four weeks post-dermal filler. The risk is not primarily about the microneedling treatment itself — it is about mechanical disruption of recently placed product through needle channels and the associated inflammatory response, which can cause product migration, altered distribution, or faster degradation.

Building a Comprehensive Pre-Treatment Screening Protocol

Contraindication knowledge is only as protective as the screening process that applies it. An esthetician who understands every contraindication on this list but uses a one-page intake form with four yes-or-no questions is not meaningfully protected — nor is their client. Building a screening protocol that actually surfaces contraindications requires deliberate intake form design, pre-appointment communication, verbal confirmation at the chair, and a clinical decision framework for handling positive screens.

Intake Form Design: What to Ask and How to Ask It

Effective intake forms for microneedling must go beyond general health history templates. Every field on the form should have a direct contraindication connection. Vague questions produce vague answers that do not give estheticians the information they need. Specificity in the question produces usability in the answer.

Verbal Confirmation at the Chair: The Second Screen

Written intake forms are the first layer of screening — verbal review at the appointment is the second, and it captures what forms miss. Many clients answer written questions differently than they answer direct verbal questions from a professional they are sitting across from. Asking “I see you answered no to recent medications — just to double-check, have you taken anything for your skin in the past year, including Accutane or any prescription creams?” frequently surfaces information that the form did not. This is not redundancy — it is professional due diligence.

Documentation When Declining or Modifying Treatment

When an esthetician identifies a contraindication and declines or modifies treatment, that decision should be documented in the client record along with the reason for the decision, what was communicated to the client, and any referral recommendations that were made. This documentation protects the esthetician in the event of a future dispute and demonstrates the professional standard of care that was applied.

How to Professionally Decline a Client for Microneedling

Knowing when to decline treatment is only half the professional competency — knowing how to communicate that decision in a way that maintains the client relationship, protects the client’s wellbeing, and reflects professional confidence is the other half. Estheticians who feel uncomfortable declining treatment are more likely to proceed in marginal situations, which increases the risk to clients and the practice.

Language That Protects and Informs Without Alarming

The goal when declining microneedling for a contraindicated client is to explain the reasoning clearly, recommend an appropriate path forward, and preserve the relationship for future appointments when the client may be eligible. A client who understands why they cannot receive the treatment today — and who sees that the decision was made in their best interest — is far more likely to return, to follow the recommended preparation steps, and to trust the esthetician’s professional judgment going forward.

Effective communication in this context is direct but not alarming, specific but not overly clinical, and always focused on what the client can do rather than simply what cannot be done at this appointment. “I want to make sure we get the best and safest result for your skin, and right now your skin is in an active phase that means today’s treatment would not be the right choice — here is what I recommend before we reschedule” is more effective than either vague deflection or a list of risks that frightens a client without actionable guidance.

When to Refer Out vs. When to Simply Reschedule

Not all contraindications require a medical referral — some simply require rescheduling after the condition has resolved. An active rosacea flare that will likely settle in two weeks does not require a physician visit before the client can be rebooked. Active herpes simplex with a documented history requires physician guidance before microneedling is ever performed on that client. Knowing which situation requires which response is part of professional contraindication competency.

When physician referral is appropriate, estheticians should be able to articulate specifically what information they need from the physician — not simply “clearance for facial treatment.” “My client is interested in microneedling for collagen induction and has a documented history of cold sores — I want to ensure appropriate antiviral prophylaxis is in place before proceeding” gives the physician context and produces a more useful response than an unspecific clearance request.